Scarica l'app Stockscreener
0.3003
1.54%
-0.0047
Precedente Chiudi:
$0.305
Aprire:
$0.3
Volume 24 ore:
217.36K
Relative Volume:
0.28
Capitalizzazione di mercato:
$28.54M
Reddito:
$1.22M
Utile/perdita netta:
$-14.15M
Rapporto P/E:
-1.155
EPS:
-0.26
Flusso di cassa netto:
$-6.55M
1 W Prestazione:
+3.20%
1M Prestazione:
+0.77%
6M Prestazione:
-17.95%
1 anno Prestazione:
-9.37%
Intervallo 1D:
$0.2997
$0.3088
Intervallo di 1 settimana:
$0.2877
$0.315
Portata 52W:
$0.2525
$0.4985
IGC Pharma Inc Stock (IGC) Company Profile
Nome
IGC Pharma Inc
Settore
Industria
Telefono
301-983-0998
Indirizzo
4336 Montgomery Avenue, Bethesda, MD
Confronta IGC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.3003 | 28.99M | 1.22M | -14.15M | -6.55M | -0.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
IGC Pharma Inc Borsa (IGC) Ultime notizie
Why IGC Pharma Inc. stock gets analyst attentionQuarterly Performance Summary & Consistent Return Strategy Ideas - ulpravda.ru
Will IGC Pharma Inc. stock deliver long term returnsJuly 2025 Selloffs & Advanced Swing Trade Entry Alerts - ulpravda.ru
Can IGC Pharma Inc. stock sustain revenue momentum2025 Investor Takeaways & Low Volatility Stock Suggestions - ulpravda.ru
Is IGC Pharma Inc. stock attractive after correctionProfit Target & Low Risk High Reward Trade Ideas - ulpravda.ru
Does IGC Pharma Inc. (IGS1) stock trade below intrinsic value2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - ulpravda.ru
Will IGC Pharma Inc. stock outperform Dow Jones indexJuly 2025 EndofMonth & High Win Rate Trade Alerts - ulpravda.ru
How IGC Pharma Inc. stock benefits from strong dollarSell Signal & Consistent Profit Trade Alerts - ulpravda.ru
Can IGC Pharma Inc. stock outperform in 2025 bull market2025 Earnings Impact & Fast Gain Stock Tips - ulpravda.ru
Can IGC Pharma Inc. stock double in next 5 yearsWeekly Volume Report & Weekly Top Performers Watchlists - ulpravda.ru
How IGC Pharma Inc. stock reacts to inflationary pressuresMarket Movers & Fast Momentum Entry Tips - ulpravda.ru
How dovish Fed policy supports IGC Pharma Inc. (IGS1) stockMarket Risk Analysis & Technical Buy Zone Confirmation - ulpravda.ru
Can IGC Pharma Inc. (IGS1) stock sustain institutional flowsCandlestick Pattern Analysis & Smart Trading Plans for Every Investor Type - bollywoodhelpline.com
IGC Pharma (IGC) Aligns Fiscal Year with Calendar Year - GuruFocus
IGC Pharma Aligns Fiscal Year with Calendar Year to Enhance U.S. Investor Transparency and Comparability - Finviz
IGC Pharma (NYSE American: IGC) prices direct 779,997-share stock sale - Stock Titan
This drug developer is switching its fiscal year to match your calendar - Stock Titan
IGC Pharma Announces Registered Direct Equity Offering Financing - TipRanks
IGC Pharma Signs Subscription Agreement With Certain Investors - TradingView — Track All Markets
How IGC Pharma Inc. (IGS1) stock expands through international marketsAutomated Trading Signals & Low Cost Capital Gains - ulpravda.ru
IGC Pharma Raises Capital to Advance IGC-AD1 Phase 2 Trial - BioSpace
IGC Pharma (NYSE American: IGC) plans $234K registered stock sale - Stock Titan
IGC Pharma (IGC) Secures Funding Through Share Sale - GuruFocus
Small biotech secures cash to keep its Alzheimer's trial moving - Stock Titan
IGC Pharma adjusts fiscal year-end to December 31 - MSN
IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates - MSN
IGC Pharma Adjusts Fiscal Year-End to December 31 - TipRanks
IGC Pharma (IGC) shifts fiscal year-end to December 31 with 9‑month transition - Stock Titan
IGC Pharma, Inc. Approves Change in the Fiscal Year-End from March 31 to December 31 - MarketScreener
IGC Pharma (IGC) Institutional Ownership 2026 - MarketBeat
IGC Pharma increases authorized shares to 600 million - MSN
Operating cash flow per share of IGC Pharma, Inc. – SWB:IGS1 - TradingView — Track All Markets
IGC Pharma Inc. (IGC) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
Would You Still Hold IGC Pharma Stock If It Fell Another 30%? - Trefis
IGC Pharma (FRA:IGS1) EV-to-OCF : -4.65 (As of Dec. 21, 2025) - GuruFocus
How IGC Pharma Inc. stock responds to policy changesWeekly Trend Summary & Long-Term Capital Growth Strategies - Улправда
IGC Pharma Secures New U.S. Patent as Pharmaceutical Cannabinoids Gain Regulatory Momentum - Big News Network.com
Will IGC Pharma Inc. stock outperform benchmarksInflation Watch & Verified Swing Trading Watchlists - Улправда
IGC Pharma Secures U.S. Patent for Innovative Stuttering Treatme - GuruFocus
What makes IGC Pharma Inc. stock appealing to growth investors2025 Trading Volume Trends & Accurate Buy Signal Notifications - DonanımHaber
Can IGC Pharma Inc. stock deliver strong Q4 earningsWeekly Investment Summary & Technical Buy Zone Confirmation - DonanımHaber
Why IGC Pharma Inc. stock remains stableJuly 2025 Selloffs & Low Risk Growth Stock Ideas - DonanımHaber
Aug Analyst Calls: How IGC Pharma Inc. (IGS1) stock expands through international markets2025 Pullback Review & Long-Term Growth Stock Strategies - Улправда
IGC Pharma Inc - Reuters
IGC Pharma comments on potential reclassification of cannabis - MSN
IGC Pharma Increases Authorized Shares to 600 Million - The Globe and Mail
IGC Pharma Inc Azioni (IGC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):